List of Tables
    Table 1. Gene Therapy On Cardiovascular Disease Market Opportunities & Trends in Global Market
    Table 2. Gene Therapy On Cardiovascular Disease Market Drivers in Global Market
    Table 3. Gene Therapy On Cardiovascular Disease Market Restraints in Global Market
    Table 4. Key Players of Gene Therapy On Cardiovascular Disease in Global Market
    Table 5. Top Gene Therapy On Cardiovascular Disease Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Gene Therapy On Cardiovascular Disease Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Gene Therapy On Cardiovascular Disease Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Gene Therapy On Cardiovascular Disease Product Type
    Table 9. List of Global Tier 1 Gene Therapy On Cardiovascular Disease Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Gene Therapy On Cardiovascular Disease Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Gene Therapy On Cardiovascular Disease Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Gene Therapy On Cardiovascular Disease Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Gene Therapy On Cardiovascular Disease Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Gene Therapy On Cardiovascular Disease Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Gene Therapy On Cardiovascular Disease Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Gene Therapy On Cardiovascular Disease Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2023-2028
    Table 30. Biogen Corporate Summary
    Table 31. Biogen Gene Therapy On Cardiovascular Disease Product Offerings
    Table 32. Biogen Gene Therapy On Cardiovascular Disease Revenue (US$, Mn), (2017-2022)
    Table 33. Novartis Corporate Summary
    Table 34. Novartis Gene Therapy On Cardiovascular Disease Product Offerings
    Table 35. Novartis Gene Therapy On Cardiovascular Disease Revenue (US$, Mn), (2017-2022)
    Table 36. Gilead Sciences Corporate Summary
    Table 37. Gilead Sciences Gene Therapy On Cardiovascular Disease Product Offerings
    Table 38. Gilead Sciences Gene Therapy On Cardiovascular Disease Revenue (US$, Mn), (2017-2022)
    Table 39. Sarepta Therapeutics Corporate Summary
    Table 40. Sarepta Therapeutics Gene Therapy On Cardiovascular Disease Product Offerings
    Table 41. Sarepta Therapeutics Gene Therapy On Cardiovascular Disease Revenue (US$, Mn), (2017-2022)
    Table 42. Alnylam Pharmaceuticals Corporate Summary
    Table 43. Alnylam Pharmaceuticals Gene Therapy On Cardiovascular Disease Product Offerings
    Table 44. Alnylam Pharmaceuticals Gene Therapy On Cardiovascular Disease Revenue (US$, Mn), (2017-2022)
    Table 45. Amgen Corporate Summary
    Table 46. Amgen Gene Therapy On Cardiovascular Disease Product Offerings
    Table 47. Amgen Gene Therapy On Cardiovascular Disease Revenue (US$, Mn), (2017-2022)
    Table 48. Spark Therapeutics Corporate Summary
    Table 49. Spark Therapeutics Gene Therapy On Cardiovascular Disease Product Offerings
    Table 50. Spark Therapeutics Gene Therapy On Cardiovascular Disease Revenue (US$, Mn), (2017-2022)
    Table 51. Akcea Therapeutics Corporate Summary
    Table 52. Akcea Therapeutics Gene Therapy On Cardiovascular Disease Product Offerings
    Table 53. Akcea Therapeutics Gene Therapy On Cardiovascular Disease Revenue (US$, Mn), (2017-2022)
    Table 54. bluebird bio Corporate Summary
    Table 55. bluebird bio Gene Therapy On Cardiovascular Disease Product Offerings
    Table 56. bluebird bio Gene Therapy On Cardiovascular Disease Revenue (US$, Mn), (2017-2022)
    Table 57. Sunway Biotech Corporate Summary
    Table 58. Sunway Biotech Gene Therapy On Cardiovascular Disease Product Offerings
    Table 59. Sunway Biotech Gene Therapy On Cardiovascular Disease Revenue (US$, Mn), (2017-2022)
    Table 60. SIBIONO Corporate Summary
    Table 61. SIBIONO Gene Therapy On Cardiovascular Disease Product Offerings
    Table 62. SIBIONO Gene Therapy On Cardiovascular Disease Revenue (US$, Mn), (2017-2022)
    Table 63. AnGes Corporate Summary
    Table 64. AnGes Gene Therapy On Cardiovascular Disease Product Offerings
    Table 65. AnGes Gene Therapy On Cardiovascular Disease Revenue (US$, Mn), (2017-2022)
    Table 66. Orchard Therapeutics Corporate Summary
    Table 67. Orchard Therapeutics Gene Therapy On Cardiovascular Disease Product Offerings
    Table 68. Orchard Therapeutics Gene Therapy On Cardiovascular Disease Revenue (US$, Mn), (2017-2022)
    Table 69. Human Stem Cells Institute Corporate Summary
    Table 70. Human Stem Cells Institute Gene Therapy On Cardiovascular Disease Product Offerings
    Table 71. Human Stem Cells Institute Gene Therapy On Cardiovascular Disease Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Gene Therapy On Cardiovascular Disease Segment by Type in 2021
    Figure 2. Gene Therapy On Cardiovascular Disease Segment by Application in 2021
    Figure 3. Global Gene Therapy On Cardiovascular Disease Market Overview: 2020
    Figure 4. Key Caveats
    Figure 5. Global Gene Therapy On Cardiovascular Disease Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Gene Therapy On Cardiovascular Disease Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Gene Therapy On Cardiovascular Disease Revenue in 2021
    Figure 8. By Type - Global Gene Therapy On Cardiovascular Disease Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Gene Therapy On Cardiovascular Disease Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Gene Therapy On Cardiovascular Disease Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Gene Therapy On Cardiovascular Disease Revenue Market Share, 2017-2028
    Figure 12. US Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Gene Therapy On Cardiovascular Disease Revenue Market Share, 2017-2028
    Figure 16. Germany Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2017-2028
    Figure 17. France Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Gene Therapy On Cardiovascular Disease Revenue Market Share, 2017-2028
    Figure 24. China Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2017-2028
    Figure 28. India Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Gene Therapy On Cardiovascular Disease Revenue Market Share, 2017-2028
    Figure 30. Brazil Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Gene Therapy On Cardiovascular Disease Revenue Market Share, 2017-2028
    Figure 33. Turkey Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2017-2028
    Figure 37. Biogen Gene Therapy On Cardiovascular Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Novartis Gene Therapy On Cardiovascular Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Gilead Sciences Gene Therapy On Cardiovascular Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Sarepta Therapeutics Gene Therapy On Cardiovascular Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Alnylam Pharmaceuticals Gene Therapy On Cardiovascular Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Amgen Gene Therapy On Cardiovascular Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Spark Therapeutics Gene Therapy On Cardiovascular Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Akcea Therapeutics Gene Therapy On Cardiovascular Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. bluebird bio Gene Therapy On Cardiovascular Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Sunway Biotech Gene Therapy On Cardiovascular Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. SIBIONO Gene Therapy On Cardiovascular Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 48. AnGes Gene Therapy On Cardiovascular Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 49. Orchard Therapeutics Gene Therapy On Cardiovascular Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 50. Human Stem Cells Institute Gene Therapy On Cardiovascular Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)